Andrew G Long's Net Worth

$6.23 Million

Estimate Recalculated Sep 8, 2024 07:35PM EST

Who is Andrew G Long?

Andrew G Long has an estimated net worth of $6.23 Million. This is based on reported shares across multiple companies, which include OWENS & MINOR INC/VA/, and Insys Therapeutics, Inc..

SEC CIK

Andrew G Long's CIK is 0001714880

Past Insider Trading and Trends

2019 was Andrew G Long's most active year for acquiring shares with 7 total transactions. Andrew G Long's most active month to acquire stocks was the month of February. 2021 was Andrew G Long's most active year for disposing of shares, totalling 4 transactions. Andrew G Long's most active month to dispose stocks was the month of April. 2019 saw Andrew G Long paying a total of $0.00 for 539,149 shares, this is the most they've acquired in one year. In 2024 Andrew G Long cashed out on 121,055 shares for a total of $1,110,815.31, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

OWENS & MINOR INC/VA/ (OMI) Snapshot price: $15.49

EVP, CEO P&HS

Andrew G Long owns 151,510 units of Common Stock which is worth $2,346,889.90. From 2019 to 2024 Andrew G Long acquired a total of 495,178 shares in OWENS & MINOR INC/VA/, Andrew also disposed a total of 343,668 shares of OWENS & MINOR INC/VA/ equalling to $3,885,126.45.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-31.88%
-70.90K
—
—
151.51K
Aug 8
Form 4
-10.96%
-27.37K
$19.78
-$541,418.16
222.41K
May 15
Form 4
-8.36%
-22.79K
$24.99
-$569,397.15
249.78K
Mar 15
Form 4
+22.87%
50.73K
—
—
272.56K
Mar 1
Form 4
-34.25%
-115.56K
—
—
221.83K
May 19
Form 4
-2.39%
-8.27K
$18.73
-$154,822.18
337.39K
May 15
Form 4
-2.04%
-7.19K
$18.39
-$132,150.54
345.65K
May 11
Form 4
-8.66%
-33.47K
$13.06
-$437,131.26
352.84K
Mar 15
Form 4
+101.83%
194.9K
—
—
386.31K
Mar 1
Form 4
-3.74%
-7.44K
$21.29
-$158,440.18
191.41K
Nov 11
Form 4
-2.10%
-4.27K
$36.05
-$153,825.35
198.85K
May 16
Form 4
-3.42%
-7.18K
$37.62
-$270,299.70
203.12K
May 11
Form 4
+14.66%
26.89K
—
—
210.3K
Mar 3
Form 4
+111.16%
96.55K
—
—
183.41K
Feb 9
Form 4
-16.94%
-17.71K
$42.16
-$746,736.74
86.86K
Scheduled
Nov 11 - Nov 12
Form 4
-9.89%
-11.47K
$38.56
-$442,360.32
104.57K
Scheduled
Aug 9
Form 4
-4.08%
-4.94K
$33.41
-$165,078.81
116.04K
May 11
Form 4
+29.87%
27.83K
—
—
120.98K
Mar 1
Form 4
-5.21%
-5.12K
$22.17
-$113,466.06
93.16K
Nov 11
Form 4
+96.55%
48.28K
—
—
98.28K
May 11
Form 4
∞
50K
—
—
50K
Nov 11
Form 3
—
0
—
—
0
No matching records found

Insys Therapeutics, Inc. No price found

Chief Executive Officer

Andrew G Long owns 62,075 units of Common Stock. In the year 2017 Andrew G Long filed a total of 7 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+25.15%
12.47K
—
—
62.08K
Apr 17
Form 4
+396.00%
39.6K
—
—
49.6K
Mar 5 - Jan 25
Form 4
+396.00%
39.6K
—
—
49.6K
Mar 5 - Jan 25
Form 4
∞
5K
—
—
5K
Aug 7
Form 4
—
0
—
—
0
Nov 17
Form 4
—
0
—
—
0
Aug 7
Form 3
—
0
—
—
0
No matching records found